
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic reprogramming and epigenetic modifications on the path to cancer
Linchong Sun, Huafeng Zhang, Ping Gao
Protein & Cell (2021) Vol. 13, Iss. 12, pp. 877-919
Open Access | Times Cited: 419
Linchong Sun, Huafeng Zhang, Ping Gao
Protein & Cell (2021) Vol. 13, Iss. 12, pp. 877-919
Open Access | Times Cited: 419
Showing 26-50 of 419 citing articles:
Metabolic Recoding of NSUN2‐Mediated m5C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m5C‐ENO1 Positive Feedback Loop
Baoxiang Chen, Yanrong Deng, Yuntian Hong, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 19
Baoxiang Chen, Yanrong Deng, Yuntian Hong, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 19
Regulation of newly identified lysine lactylation in cancer
Xin Gao, Chaoyu Pang, Zhiyao Fan, et al.
Cancer Letters (2024) Vol. 587, pp. 216680-216680
Closed Access | Times Cited: 15
Xin Gao, Chaoyu Pang, Zhiyao Fan, et al.
Cancer Letters (2024) Vol. 587, pp. 216680-216680
Closed Access | Times Cited: 15
Cancer Epigenetics: An Overview
Félix Recillas‐Targa
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 732-740
Open Access | Times Cited: 60
Félix Recillas‐Targa
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 732-740
Open Access | Times Cited: 60
Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
LDHA promotes osteoblast differentiation through histone lactylation
Feige Nian, Yezhou Qian, Fangyan Xu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 615, pp. 31-35
Closed Access | Times Cited: 51
Feige Nian, Yezhou Qian, Fangyan Xu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 615, pp. 31-35
Closed Access | Times Cited: 51
Recent findings in the regulation of G6PD and its role in diseases
Qingfei Meng, Yanghe Zhang, Shiming Hao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51
Qingfei Meng, Yanghe Zhang, Shiming Hao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 51
New dawn for cancer cell death: Emerging role of lipid metabolism
Chanjuan Zhang, Neng Zhu, Hongfang Li, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101529-101529
Open Access | Times Cited: 48
Chanjuan Zhang, Neng Zhu, Hongfang Li, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101529-101529
Open Access | Times Cited: 48
Lactylation: novel epigenetic regulatory and therapeutic opportunities
Haoqin Fan, Fan Yang, Zhenghui Xiao, et al.
AJP Endocrinology and Metabolism (2023) Vol. 324, Iss. 4, pp. E330-E338
Closed Access | Times Cited: 38
Haoqin Fan, Fan Yang, Zhenghui Xiao, et al.
AJP Endocrinology and Metabolism (2023) Vol. 324, Iss. 4, pp. E330-E338
Closed Access | Times Cited: 38
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination
Jun‐Han Wang, Ling Mao, Jun Wang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 465-480
Closed Access | Times Cited: 34
Jun‐Han Wang, Ling Mao, Jun Wang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 465-480
Closed Access | Times Cited: 34
Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma
Han Hong, Xi Chen, Honggang Wang, et al.
PROTEOMICS (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 32
Han Hong, Xi Chen, Honggang Wang, et al.
PROTEOMICS (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 32
Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma
Qi Feng, Jia Li, Zhuoran Qi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 30
Qi Feng, Jia Li, Zhuoran Qi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 30
Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression
Dongmei Gou, Rui Liu, Xiaoqun Shan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 29
Dongmei Gou, Rui Liu, Xiaoqun Shan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 29
Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin
Francisco Canindé Ferreira de Luna, Wallax Augusto Silva Ferreira, Samir Mansour Moraes Casseb, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1229-1229
Open Access | Times Cited: 28
Francisco Canindé Ferreira de Luna, Wallax Augusto Silva Ferreira, Samir Mansour Moraes Casseb, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1229-1229
Open Access | Times Cited: 28
Histone lactylation regulates cancer progression by reshaping the tumor microenvironment
Junxing Qu, Peizhi Li, Zhiheng Sun
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Junxing Qu, Peizhi Li, Zhiheng Sun
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy
Yilin Yu, Jie Yu, Shengfang Ge, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 3, pp. 811-828
Open Access | Times Cited: 23
Yilin Yu, Jie Yu, Shengfang Ge, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 3, pp. 811-828
Open Access | Times Cited: 23
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Mitophagy and clear cell renal cell carcinoma: insights from single-cell and spatial transcriptomics analysis
Lai Jiang, Xing Ren, Jinyan Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Lai Jiang, Xing Ren, Jinyan Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Role of LMO7 in cancer (Review)
Qun Zeng, Tingting Jiang, Jing Wang
Oncology Reports (2024) Vol. 52, Iss. 3
Closed Access | Times Cited: 14
Qun Zeng, Tingting Jiang, Jing Wang
Oncology Reports (2024) Vol. 52, Iss. 3
Closed Access | Times Cited: 14
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
Yuanxiang Lu, Jinghan Zhu, Yuxin Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 14
Yuanxiang Lu, Jinghan Zhu, Yuxin Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 14
Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer
Jie Ren, Bo Ren, Xiaohong Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216649-216649
Closed Access | Times Cited: 13
Jie Ren, Bo Ren, Xiaohong Liu, et al.
Cancer Letters (2024) Vol. 587, pp. 216649-216649
Closed Access | Times Cited: 13
Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side
Yongxin Yu, Yulang Jiang, Christian Glandorff, et al.
Cellular Signalling (2024) Vol. 120, pp. 111239-111239
Closed Access | Times Cited: 13
Yongxin Yu, Yulang Jiang, Christian Glandorff, et al.
Cellular Signalling (2024) Vol. 120, pp. 111239-111239
Closed Access | Times Cited: 13
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
Andrea Nicolini, Paola Ferrari
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Andrea Nicolini, Paola Ferrari
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD)
Antonella Mosca, Melania Manco, Maria Rita Braghini, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 11
Antonella Mosca, Melania Manco, Maria Rita Braghini, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 11
Supramolecular Hydrogel with Ultra‐Rapid Cell‐Mediated Network Adaptation for Enhancing Cellular Metabolic Energetics and Tissue Regeneration
Zhuo Li, Boguang Yang, Zhengmeng Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 11
Zhuo Li, Boguang Yang, Zhengmeng Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 11